Should BRCA Mutations Be Used For Breast Cancer Screening?

Should BRCA Mutations Be Used For Breast Cancer Screening?
shutterstock_153451205It is estimated that 235,000 new cases of breast cancer are diagnosed each year in the United States with more than 40,000 patients dying annually. For some time now, the medical and scientific community has discussed the risks and benefits of screening for breast cancer by using the BRCA1 and BRCA2 mutations in the general and adult population, since it is crucial to determine if women are predisposed genetically to breast cancer. Glenn E. Palomaki, PhD, director of the Division of Medical Screening and Special Testing at Women & Infants Hospital of Rhode Island, recently published in the November issue of the journal Genetics in Medicine a scientific commentary entitled 'Is it time forBRCA1/2 mutation screening in the general adult population? Impact of population characteristics". There are well established criteria by the United States Preventive Services Task Force and the National Comprehensive Cancer Network agencies when it comes to evaluating patients with high risk factors for breast cancer. If there are records of ovarian and breast cancer withi
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.